Company reports Q2 revenue of $72 million, citing equipment sales weakness as a key challenge ahead of reverse split vote.
SkinHealth Systems projected Q2 2026 revenue of $280M-$290M, aligning with earlier guidance but reflecting ongoing pressure. The company reported Q2 revenue of $72 million, landing at the lower end of its forecast range.
Management attributed the mixed performance to sluggish equipment sales, as providers delay purchases. The prior quarter’s revenue and consensus estimates were not disclosed, but the guidance range remains unchanged from earlier projections.
The company is preparing for a September 22 shareholder vote on a reverse stock split, a move often aimed at boosting share price stability.